We are live on
!
Find out more
SCM
Smead Capital Management Portfolio holdings
AUM
$4.6B
1-Year Est. Return
27.56%
This Fund
S&P 500
This Quarter
Est. Return
+19.84%
1 Year Est. Return
+27.56%
3 Year Est. Return
+64.97%
5 Year Est. Return
+125.46%
10 Year Est. Return
+462.58%
AUM
$2.27B
AUM Growth
+$542M
(+31%)
Cap. Flow
+$212M
Cap. Flow
% of AUM
9.33%
Top 10 Holdings %
Top 10 Hldgs %
51.81%
Holding
37
New
5
Increased
23
Reduced
7
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$60.7M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$51.7M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$33.2M |
| 4 |
Macerich
MAC
|
+$27.6M |
| 5 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$26.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$110M |
| 2 |
Walt Disney
DIS
|
+$11M |
| 3 |
Target
TGT
|
+$9.46M |
| 4 |
Accenture
ACN
|
+$9.4M |
| 5 |
Starbucks
SBUX
|
+$4.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.73% |
| 2 | Financials | 19.01% |
| 3 | Healthcare | 13.77% |
| 4 | Communication Services | 8.09% |
| 5 | Real Estate | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Credit Acceptance
CACC
$6.08B
| $32.1M | 1.41% |
89,177
+7,464
| +9% | +$2.71M |
|
27
Carter's
CRI
$1.47B
| $29.1M | 1.28% |
327,720
+27,007
| +9% | +$2.5M |
|
|
28
Accenture
ACN
$108B
| $24M | 1.06% |
87,029
-36,369
| -29% | -$9.4M |
|
29
Ulta Beauty
ULTA
$24.3B
| $21.4M | 0.94% |
69,230
+6,361
| +10% | +$1.98M |
|
|
30
Starbucks
SBUX
$120B
| $9.86M | 0.43% |
90,264
-42,588
| -32% | -$4.47M |
|
31
Occidental Petroleum Corp Warrants
OXY.WS
$32B
| $567K | 0.03% |
47,573
+898
| +2% | +$10.1K |
|
32
West Fraser Timber
WFG
$5.65B
| $413K | 0.02% |
+5,744
| New | +$386K |
|
33
Liberty Global Class C
LBTYK
$3.49B
| $236K | 0.01% |
9,253
+175
| +2% | +$4.38K |
|
34
Cenovus Energy
CVE
$52.1B
| $162K | 0.01% |
+21,589
| New | +$152K |
|
|
CVE.WS
35
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
| $106K | ﹤0.01% |
+26,691
| New | +$93K |
|
36
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| – | – |
-1,352
| Closed | -$505K |
|
37
Viatris
VTRS
$19.1B
| – | – |
-143,553
| Closed | -$2.69M |
|
Similar funds
LNWTC
SV
SCM
VCM
ACM
ASC
BJL
MA
Smead Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Smead Capital Management held 37 positions worth $2.27B, up 31% from $1.73B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Smead Capital Management deployed $212M of net new capital in Q1 2021, opening 5 new positions and adding to 23 existing holdings. Its largest new stake was Discovery, Inc. Series C Common Stock: 1,218,844 shares worth $45M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Warner Bros, an estimated $110M trimmed.
- Smead Capital Management's largest Q1 2021 buy was Discovery, Inc. Series C Common Stock: 1,218,844 shares worth $45M.
- Smead Capital Management added most to Merck in Q1 2021, an estimated $60.7M increase.
- Smead Capital Management's biggest Q1 2021 reduction was Warner Bros, cutting an estimated $110M.
- Smead Capital Management fully exited Viatris in Q1 2021, selling an estimated $2.69M.
- Smead Capital Management's ten largest holdings make up 52% of its $2.27B portfolio in Q1 2021.
- Smead Capital Management opened 5 new positions and closed 2 in Q1 2021.
- Smead Capital Management's portfolio value rose 31% quarter-over-quarter to $2.27B.
Based on Smead Capital Management's 13F filing for Q1 2021, filed 4 May 2021.